• Japanese
  • Korean
  • Chinese
Cover Image

US Markets for Orthopedic Biomaterials 2014

Notes

Despite recent obstacles, such as product approval denials, changes to treatment recommendations and a challenging economic environment, ongoing adoption of these products continues and overall interest in the use of these products remains high.

The US orthopedic biomaterial market remains a segment of higher growth in comparison to many other orthopedic markets. Despite recent obstacles, such as product approval denials, changes to treatment recommendations, and a challenging economic environment, ongoing adoption of these products continues and overall interest in the use of these products remains high.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the US market across a 10-year period.

Questions Answered in This Report:

  • In 2013, Medtronic's INFUSE growth factor product faced continuing revenue declines, while the FDA failed to approve Wright Medical Technology's Augment Bone Graft.
    • How will growth of the overall BGS market be impacted by ongoing hindrance of its largest revenue segment?
    • Which BGS product segments will benefit from declining utilization of growth factor products?
  • Zimmer's Gel-One product was released into the HA viscosupplementation market in early 2013.
    • How will its introduction impact the single-injection market?
    • What does the future look like for the other injection segments?
  • The ongoing launch of new nonbone IBDs will impact adoption and thus revenues in the machined bone IBD market.
    • What factors will drive the uptake of nonbone IBDs, and will the machined bone IBD market be able to maintain some growth through 2022?
    • Which approaches are most likely to see growth or decline?
  • Despite a lack of confidence in the clinical data available for some cell concentration systems, procedure volumes will grow moderately.
    • Which applications are utilizing these systems the most frequently?
    • Will the higher cost BMAC systems be able to maintain strong procedure growth during challenging economic times?

Scope:

Geographies Covered: US.

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012-2022).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

1. COUNTRY OVERVIEWS

  • 1.1. US
    • 1.1.1. Demographics and Economy
    • 1.1.2. Health Care System
    • 1.1.3. Regulatory Environment

2. CLINICAL LANDSCAPE

  • 2.1. Background
  • 2.1.1. Arthritis
  • 2.2. Procedure Descriptions
    • 2.2.1. Bone Graft Procedures
      • 2.2.1.1. Thoracolumbar and Cervical Spinal Fusions
      • 2.2.1.2. Trauma Surgeries
      • 2.2.1.3. Large-Joint Revision and Reconstruction Procedures
      • 2.2.1.4. Extremity Surgeries
      • 2.2.1.5. Craniomaxillofacial Surgeries
    • 2.2.2. Hyaluronic Acid Viscosupplementation Treatments
    • 2.2.3. Interbody Fusions
    • 2.2.4. Cell Concentration System Procedures
  • 2.3. Competing Treatments
    • 2.3.1. Nonpharmacologic Treatments
    • 2.3.2. Nonsteroidal Anti-Inflammatory Drugs
    • 2.3.3. Cyclooxygenase-2 Inhibitors
    • 2.3.4. Steroid Injections
    • 2.3.5. Bariatric Surgery
    • 2.3.6. Nonfusion Technologies
    • 2.3.7. Joint Arthroplasty
    • 2.3.8. Additional Competing Treatments for Bone Graft Substitutes

3. PRODUCTS

  • 3.1. Bone Grafts
    • 3.1.1. Autografts
    • 3.1.2. Growth Factors
    • 3.1.3. Demineralized Bone Matrices
    • 3.1.4. Orthopedic Stem Cell Products
    • 3.1.5. Nonproprietary Allografts
    • 3.1.6. Synthetics
      • 3.1.6.1. First-Generation Synthetics
      • 3.1.6.2. Second-Generation Synthetics
    • 3.1.7. Xenografts
  • 3.2. Hyaluronic Acid Viscosupplementation Products
  • 3.3. Machined Bone Interbody Devices
    • 3.3.1. Anterior Lumbar Interbody Fusion
    • 3.3.2. Posterior Lumbar Interbody Fusion
    • 3.3.3. Transforaminal Lumbar Interbody Fusion
    • 3.3.4. Lateral Lumbar Interbody Fusion
    • 3.3.5. Cervical Interbody Fusion
    • 3.3.6. Differentiating Features
  • 3.4. Cell Concentration Systems
    • 3.4.1. Platelet Concentration Systems
    • 3.4.2. Bone Marrow Aspirate Concentrate Systems
    • 3.4.3. Bone Marrow Aspirate Systems

4. CLINICAL TRIALS

  • 4.1. Bone Graft Substitute Clinical Trials
  • 4.2. Hyaluronic Acid Viscosupplementation Clinical Trials
    • 4.2.1. Knee Applications
    • 4.2.2. Shoulder Applications
    • 4.2.3. Other Joint Applications
  • 4.3. Cell Concentration System Clinical Trials

5. ORTHOPEDIC BIOMATERIAL MARKET

  • 5.1. Market Snapshot
  • 5.2. Detailed Market Analysis
  • 5.3. Competitive Snapshot
  • 5.4. Market Shares
  • 5.5. Recent Events
  • 5.6. Most Promising Emerging Products

6. BONE GRAFT SUBSTITUTE MARKET

  • 6.1. Market Snapshot
  • 6.2. Detailed Market Analysis
    • 6.2.1. By Material
      • 6.2.1.1. Autografts (Procedures Only)
      • 6.2.1.2. Growth Factors
      • 6.2.1.3. Demineralized Bone Matrices
      • 6.2.1.4. Orthopedic Stem Cell Products
      • 6.2.1.5. Nonproprietary Allografts
      • 6.2.1.6. First- and Second-Generation Synthetics
    • 6.2.2. By Procedure Type
      • 6.2.2.1. Spinal Fusion
        • 6.2.2.1.1. By Approach
        • 6.2.2.1.2. By Anatomy
          • 6.2.2.1.2.1. Thoracolumbar
          • 6.2.2.1.2.2. Cervical
      • 6.2.2.2. Trauma Surgery
      • 6.2.2.3. Large-Joint Revision and Reconstruction
      • 6.2.2.4. Extremity Surgery
      • 6.2.2.5. Craniomaxillofacial Surgery
  • 6.3. Competitive Snapshot
  • 6.4. Detailed Competitive Landscape
  • 6.5. Market Shares

7. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 7.1. Market Snapshot
  • 7.2. Detailed Market Analysis
    • 7.2.1. By Number of Injections
    • 7.2.2. By Anatomy
    • 7.2.3. By Facility Type (Qualitative Only)
  • 7.3. Competitive Snapshot
  • 7.4. Detailed Competitive Landscape
  • 7.5. Market Shares

8. MACHINED BONE INTERBODY DEVICE MARKET

  • 8.1. Market Snapshot
  • 8.2. Detailed Market Analysis
  • 8.3. Competitive Snapshot
  • 8.4. Detailed Competitive Landscape
  • 8.5. Market Shares

9. CELL CONCENTRATION SYSTEM MARKET

  • 9.1. Market Snapshot
  • 9.2. Detailed Market Analysis
  • 9.3. Competitive Snapshot
  • 9.4. Detailed Competitive Landscape
  • 9.5. Market Shares

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Orthopedic Biomaterial Market, by Product Type, US (USD), 2012-2022
  • Table 1: Orthopedic Biomaterial Market Landscape, US (USD), 2013 and 2022
  • Table 2: Orthopedic Biomaterial Market Leaders, by Product Type and Revenue, US, 2013
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Orthopedic Biomaterial Market, by Product Type, US, 2013-2022
  • Table 5: Expected Key Events in the Orthopedic Biomaterial Market, US, 2014-2022
  • Table 6: Key Report Updates
  • Table 7: Orthopedic Biomaterial Procedures Covered, US
  • Table 8: Orthopedic Biomaterial Products Covered, US

1. COUNTRY OVERVIEWS

  • Table 9: Key Health and Economic Indicators, US

2. CLINICAL LANDSCAPE

  • Table 10: Spinal Nonfusions, by Procedure Type

3. PRODUCTS

  • Table 11: Characteristics of Bone Grafts, by Material
  • Table 12: Advantages and Disadvantages of Bone Grafts, by Material
  • Table 13: Select First-Generation Synthetic BGS Materials, by Material
  • Table 14: Advantages and Disadvantages of HA Viscosupplementation Products, by Number of Injections
  • Table 15: Advantages and Disadvantages of IBDs, by Approach

4. CLINICAL TRIALS

  • Table 16: Promoting Fusion in Minimally Invasive Lumbar Interbody Stabilization with Low-Dose BMP-2-But What is the Cost?
  • Table 17: Spine Fusion Instrumented With BMP-2 versus Uninstrumented with Infuse BMP-2 Alone
  • Table 18: INFUSE Bone Graft/PEEK Interbody Spacer/Anterior Cervical Plate Pivotal Clinical Trial (ACDF)
  • Table 19: INFUSE Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine (TLIF)
  • Table 20: Actifuse ABX versus INFUSE in Posterolateral Instrumented Lumbar Fusion (PILF) with Interbody Fusion (APPRAISET1)
  • Table 21: Efficacy and Safety of Accell Evo3 DBM in Instrumented Posterolateral Lumbar Spine Fusion
  • Table 22: An Assessment of P-15 Bone Putty in Anterior Cervical Fusion with Instrumentation
  • Table 23: Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy
  • Table 24: Outcomes of Degenerative Disc Disease Patients Treated With an Anterior-Only Fusion Using InQu Bone Graft
  • Table 25: EVOKE
  • Table 26: Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee
  • Table 27: Hymovis Versus Placebo in Knee Osteoarthritis
  • Table 28: Comparative Study of Safety and Efficacy of Two Hyaluronic Acids for the Treatment of Knee Osteoarthritis
  • Table 29: Different Volumes of DUROLANE in Knee Osteoarthritis
  • Table 30: Cingal Study for Knee Osteoarthritis
  • Table 31: Efficacy and Safety of 3 Different Dosage Regimens of HA in Patients with Knee Osteoarthritis
  • Table 32: Efficacy of Three Weekly Injections of a Bacterial-Sourced Hyaluronate on Pain and Function in Patients With Knee Osteoarthritis
  • Table 33: Efficacy of Intra-Articular HA in the Knee Osteoarthritis
  • Table 34: SUPARTZ versus Placebo in Osteoarthritis of the Shoulder
  • Table 35: Three Injections of EUFLEXXA (Sodium Hyaluronate) for Treatment of Chronic Shoulder Pain Associated With Osteoarthritis
  • Table 36: Comparative Analysis of Intra-articular Injection of Steroid and/or Sodium Hyaluronate in Adhesive Capsulitis
  • Table 37: Efficacy of 3 Weekly Injections of Hyaluronate in Patients With Ankle Osteoarthritis
  • Table 38: A Double-Blind RCT of a Single Dose of Hyaluronan in the Treatment of Osteoarthritis of the Ankle
  • Table 39: Intra-Articular Injection of HA in Symptomatic Osteoarthritis of the Hip
  • Table 40: A Study of the Safety and Effectiveness of Synvisc-One (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip
  • Table 41: A Study of Hyaluronan for the Treatment of Osteoarthritis in the Thumb
  • Table 42: A Clinical Trial Evaluating Platelet Rich Plasma Versus Hyaluronic-Acid in the Short-term Treatment of Symptomatic OA (Osteoarthritis) of the Hip
  • Table 43: Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich Plasma
  • Table 44: Patellar Tendon Healing With Platelet-Rich Plasma: A Prospective Randomized Controlled Trial
  • Table 45: Platelet Rich Plasma (PRP) in Total Knee Replacement
  • Table 46: The Effect of Platelet-rich Plasma in Patients With Osteoarthritis of the Knee
  • Table 47: Comparative Assessment of Intra-articular Knee Injections of Platelet-rich Plasma (PRP) and Hyaluronic Acid in the Treatment of Knee Osteoarthritis
  • Table 48: Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma
  • Table 49: Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department (PRP)
  • Table 50: Platelet Rich Plasma vs. Corticosteroid Injection in the Treatment of Partial Rotator Cuff Tears
  • Table 51: Prospective, Multi-Center Clinical Outcomes Study Evaluating the chronOS Strip Combined With Bone Marrow Aspirate
  • Table 52: Comparing Synthetic Bone Alone versus Synthetic Bone with Bone Marrow in Bone Lesions
  • Table 53: Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis (BMAC)
  • Table 54: Regenexx SD Versus Exercise Therapy for ACL Tears
  • Table 55: Regenexx SD Versus Exercise Therapy for Rotator Cuff Tears

5. ORTHOPEDIC BIOMATERIAL MARKET

  • Figure 2: Orthopedic Biomaterial Market, by Product Type, US (USD), 2012-2022
  • Table 56: Factors Impacting the Orthopedic Biomaterial Market, by Product Type, US, 2013-2022
  • Table 57: Orthopedic Biomaterial Market, by Product Type, US (USD), 2012-2022
  • Figure 3: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, US, 2013
  • Table 58: Leading Competitors in the Orthopedic Biomaterial Market, by Product Type, as a % of Total, US, 2013
  • Table 59: Recent Events in the Orthopedic Biomaterial Market, US
  • Table 60: Emerging Products in Development for the Orthopedic Biomaterial Market, US, 2013-2022

6. BONE GRAFT SUBSTITUTE MARKET

  • Figure 4: BGS Market, by Material, US (USD), 2012-2022
  • Table 61: Bone Graft Units Used, by Material, US, 2012-2022
  • Table 62: BGS Market, by Material, US (USD), 2012-2022
  • Table 63: Growth Factor ASPs, by Package Volume, US (USD), 2013
  • Table 64: DBM ASPs, by Package Volume, US (USD), 2013
  • Table 65: Orthopedic Stem Cell Product ASPs, by Package Volume, US (USD), 2013
  • Table 66: Nonproprietary Allograft ASPs, by Package Volume, US (USD), 2013
  • Table 67: First-Generation Synthetic ASPs, by Package Volume, US (USD), 2013
  • Table 68: Second-Generation Synthetic ASPs, by Package Volume, US (USD), 2013
  • Table 69: Bone Graft Procedures, by Procedure Type, US, 2012-2022
  • Table 70: Average Volume of Bone Graft per Procedure, by Procedure Type, US, 2013
  • Table 71: BGS Market, by Procedure Type, US (USD), 2012-2022
  • Table 72: Spinal Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 73: Spinal Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 74: Spinal Fusion BGS Market, by Approach, US (USD), 2012-2022
  • Table 75: Spinal Fusion BGS Market Growth, by Approach, US, 2013-2022
  • Table 76: Spinal Fusion BGS Market, by Approach, as a % of Total, US, 2012-2022
  • Table 77: Posterolateral Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 78: Posterolateral Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 79: Posterolateral Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 80: Posterolateral Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 81: Interbody Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 82: Interbody Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 83: Interbody Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 84: Interbody Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 85: Spinal Fusion Bone Graft Procedures, by Anatomy, US, 2012-2022
  • Table 86: Thoracolumbar Fusion Bone Graft Procedures, by Scope, US, 2012-2022
  • Table 87: Thoracolumbar Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 88: Thoracolumbar Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 89: Thoracolumbar Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 90: Thoracolumbar Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 91: One-Level Thoracolumbar Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 92: One-Level Thoracolumbar Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 93: One-Level Thoracolumbar Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 94: One-Level Thoracolumbar Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 95: Two-Level Thoracolumbar Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 96: Two-Level Thoracolumbar Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 97: Two-Level Thoracolumbar Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 98: Two-Level Thoracolumbar Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 99: Multilevel Thoracolumbar Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 100: Multilevel Thoracolumbar Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 101: Multilevel Thoracolumbar Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 102: Multilevel Thoracolumbar Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 103: Cervical Fusion Bone Graft Procedures, by Scope, US, 2012-2022
  • Table 104: Cervical Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 105: Cervical Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 106: Cervical Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 107: Cervical Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 108: One-Level Cervical Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 109: One-Level Cervical Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 110: One-Level Cervical Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 111: One-Level Cervical Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 112: Two-Level Cervical Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 113: Two-Level Cervical Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 114: Two-Level Cervical Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 115: Two-Level Cervical Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 116: Multilevel Cervical Fusion Bone Graft Units Used, by Material, US, 2012-2022
  • Table 117: Multilevel Cervical Fusion BGS Market, by Material, US (USD), 2012-2022
  • Table 118: Multilevel Cervical Fusion BGS Market Growth, by Material, US, 2013-2022
  • Table 119: Multilevel Cervical Fusion BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 120: Trauma Surgery Bone Graft Procedures, by Procedure Type, US, 2012-2022
  • Table 121: Trauma Surgery Bone Graft Units Used, by Material, US, 2012-2022
  • Table 122: Trauma Surgery BGS Market, by Material, US (USD), 2012-2022
  • Table 123: Fresh Fracture Surgeries, by Procedure Type, US, 2012-2022
  • Table 124: Fresh Fracture Surgery Bone Graft Units Used, by Material, US, 2012-2022
  • Table 125: Fresh Fracture Surgery BGS Market, by Material, US (USD), 2012-2022
  • Table 126: Fresh Fracture Surgery BGS Market Growth, by Material, US, 2013-2022
  • Table 127: Fresh Fracture Surgery BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 128: Nonunion Surgery Bone Graft Units Used, by Material, US, 2012-2022
  • Table 129: Nonunion Surgery BGS Market, by Material, US (USD), 2012-2022
  • Table 130: Nonunion Surgery BGS Market Growth, by Material, US, 2013-2022
  • Table 131: Nonunion Surgery BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 132: Large-Joint Revision and Reconstruction Bone Graft Procedures, by Product Type, US, 2012-2022
  • Table 133: Large-Joint Revision and Reconstruction Bone Graft Units Used, by Material, US, 2012-2022
  • Table 134: Large-Joint Revision and Reconstruction BGS Market, by Material, US (USD), 2012-2022
  • Table 135: Primary TKAs, by Procedure Type, US, 2012-2022
  • Table 136: Primary TKA Bone Graft Units Used, by Material, US, 2012-2022
  • Table 137: Primary TKA BGS Market, by Material, US (USD), 2012-2022
  • Table 138: Primary TKA BGS Market Growth, by Material, US, 2013-2022
  • Table 139: Primary TKA BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 140: Knee Revisions, by Procedure Type, US, 2012-2022
  • Table 141: Knee Revision Bone Graft Units Used, by Material, US, 2012-2022
  • Table 142: Knee Revision BGS Market, by Material, US (USD), 2012-2022
  • Table 143: Knee Revision BGS Market Growth, by Material, US, 2013-2022
  • Table 144: Knee Revision BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 145: Primary THAs, by Procedure Type, US, 2012-2022
  • Table 146: Primary THA Bone Graft Units Used, by Material, US, 2012-2022
  • Table 147: Primary THA BGS Market, by Material, US (USD), 2012-2022
  • Table 148: Primary THA BGS Market Growth, by Material, US, 2013-2022
  • Table 149: Primary THA BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 150: Hip Revisions, by Procedure Type, US, 2012-2022
  • Table 151: Hip Revision Bone Graft Units Used, by Material, US, 2012-2022
  • Table 152: Hip Revision BGS Market, by Material, US (USD), 2012-2022
  • Table 153: Hip Revision BGS Market Growth, by Material, US, 2013-2022
  • Table 154: Hip Revision BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 155: Extremity Surgeries, by Procedure Type, US, 2012-2022
  • Table 156: Extremity Surgery Bone Graft Units Used, by Material, US, 2012-2022
  • Table 157: Extremity Surgery BGS Market, by Material, US (USD), 2012-2022
  • Table 158: Extremity Surgery BGS Market Growth, by Material, US, 2013-2022
  • Table 159: Extremity Surgery BGS Market, by Material, as a % of Total, US, 2012-2022
  • Table 160: CMF Surgeries, by Procedure Type, US, 2012-2022
  • Table 161: CMF Surgery Bone Graft Units Used, by Material, US, 2012-2022
  • Table 162: CMF Surgery BGS Market, by Material, US (USD), 2012-2022
  • Table 163: CMF Surgery BGS Market Growth, by Material, US, 2013-2022
  • Table 164: CMF Surgery BGS Market, by Material, as a % of Total, US, 2012-2022
  • Figure 5: Leading Competitors in the BGS Market, as a % of Total, US, 2013
  • Table 165: Leading Competitors in the BGS Market, by Material, as a % of Total, US, 2013

7. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Figure 6: HA Viscosupplementation Market, by Number of Injections, US (USD), 2012-2022
  • Table 166: HA Viscosupplementation Treatments and Injections, by Number of Injections, US, 2012-2022
  • Table 167: HA Viscosupplementation Market, by Number of Injections, US (USD), 2012-2022
  • Table 168: HA Viscosupplementation Market Growth, by Number of Injections, US, 2013-2022
  • Table 169: HA Viscosupplementation Market, by Number of Injections, as a % of Total, US, 2012-2022
  • Table 170: HA Viscosupplementation Treatments, by Anatomy, US, 2012-2022
  • Table 171: HA Viscosupplementation Market, by Anatomy, US (USD), 2012-2022
  • Table 172: HA Viscosupplementation Market Growth, by Anatomy, US, 2013-2022
  • Table 173: HA Viscosupplementation Market, by Anatomy, as a % of Total, US, 2012-2022
  • Figure 7: HA Viscosupplementation Revenue Market Shares, US, 2013
  • Table 174: HA Viscosupplementation Revenue Market Shares, by Number of Injections, US, 2013

8. MACHINED BONE INTERBODY DEVICE MARKET

  • Figure 8: Machined Bone IBD Market, by Approach, US (USD), 2012-2022
  • Table 175: Machined Bone IBD Fusions, by Approach, US, 2012-2022
  • Table 176: Machined Bone IBD Fusions, by Scope, as a % of Total, US, 2012-2022
  • Table 177: Machined Bone ALIFs, by Scope, as a % of Total, US, 2012-2022
  • Table 178: Machined Bone PLIFs, by Scope, as a % of Total, US, 2012-2022
  • Table 179: Machined Bone TLIFs, by Scope, as a % of Total, US, 2012-2022
  • Table 180: Machined Bone LLIFs, by Scope, as a % of Total, US, 2012-2022
  • Table 181: Machined Bone Cervical IBD Fusions, by Scope, as a % of Total, US, 2012-2022
  • Table 182: Machined Bone IBD Market, by Approach, US (USD), 2012-2022
  • Table 183: Machined Bone IBD Market Growth, by Approach, US, 2013-2022
  • Table 184: Machined Bone IBD Market, by Approach, as a % of Total, US, 2012-2022
  • Figure 9: Leading Competitors in the Machined Bone IBD Market, as a % of Total, US, 2012
  • Table 185: Leading Competitors in the Machined Bone IBD Market, as a % of Total, US, 2012

9. CELL CONCENTRATION SYSTEM MARKET

  • Figure 10: Cell Concentration System Market, by Product Type, US (USD), 2012-2022
  • Table 186: Cell Concentration System Procedures, by Product Type, US, 2012-2022
  • Table 187: Cell Concentration System Procedures, by Procedure Type, US, 2012-2022
  • Table 188: Platelet Concentration Procedures, by Procedure Type, US, 2012-2022
  • Table 189: BMAC Procedures, by Procedure Type, US, 2012-2022
  • Table 190: BMA Procedures, by Procedure Type, US, 2012-2022
  • Table 191: Cell Concentration System Market, by Product Type, US (USD), 2012-2022
  • Table 192: Platelet Concentration System Market, by Product Type, US (USD), 2012-2022
  • Table 193: Platelet Concentration System Market Growth, by Product Type, US, 2013-2022
  • Table 194: Platelet Concentration System Market, by Product Type, as a % of Total, US, 2012-2022
  • Table 195: BMAC System Market, US (USD), 2012-2022
  • Table 196: BMA System Market, US (USD), 2012-2022
  • Figure 11: Leading Competitors in the Cell Concentration System Market, as a % of Total, US, 2013
  • Table 197: Leading Competitors in the Cell Concentration System Market, by Product Type, as a % of Total, US, 2013

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

  • Table 198: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

Show More
Pricing
Get Notified
Email me when related reports are published